KZA 2.54% 57.5¢ kazia therapeutics limited

skin ulcer wound care mkt tops $2.5 bn

  1. 3,567 Posts.
    When reading this keep in mind Novogen has a skin Ulcer compound that has already entered Phase II clinical trials. The doctors are excited about this compound after successes in Phase I trials. Is there anything Novogen can't do???

    "http://biz.yahoo.com/prnews/030604/nyw162_1.html

    Skin Ulcer Wound Care Market Tops $2.5 Billion
    Wednesday June 4, 6:04 pm ET


    NEW YORK, June 4 /PRNewswire/ -- The market for wound care products aimed at the care of skin ulcers topped $2.5 billion worldwide in 2002, according to a new study released today from Kalorama Information. Skin ulcers affect approximately 18 million.
    ADVERTISEMENT


    According to the new study, Wound Care Markets Volume I: Skin Ulcers, strong growth in newer technologies has been the main driver of increased revenues, even as other, more traditional markets have begun to slow.

    "Biological dressings have finally started to significantly impact the skin ulcer market, offsetting the slower growth of the more mature segments," notes Steven Heffner, Acquisitions Editor for Kalorama Information. "These advanced wound care technologies, especially artificial skin products, are proving their cost-effectiveness and are rapidly gaining market acceptance. Our findings suggest that biological dressings to represent more than 10% of the total market as early as next year."

    According to the study, certain segments of the biological dressing market have shown annual growth in excess of 50%. Although the next few years should see a slowing trend even in these high-tech areas, demographic, regulatory, and clinical trends will still benefit these newer market entrants through the next 5 years.

    The study analyzes the worldwide market for product used in skin ulcer care, including pressure relief devices; anti-infective products; compression dressings; cleansing and debridement products; moist dressings, such as alginates, hydrocolloids, hydrogels, films, and foams; biological products such as artificial skin, collagen, and growth factors; and other skin ulcer treatments.

    The report represents the first volume of an ongoing study of wound care market segments. Volumes II and III are due out from Kalorama Information later this year and will examine the market for burn care and traumatic/surgical wound care, respectively.

    About Kalorama Information

    Kalorama Information, an imprint of MarketResearch.com, supplies the latest in independent market research for the life sciences. For more information, contact Steven Heffner at 212-807-2634 or [email protected], or visit www.KaloramaInformation.com.

    About MarketResearch.com

    MarketResearch.com is the leading provider of global market intelligence products and services. With over 50,000 research publications from 350 research publishers, we offer instant online access to the world's most extensive database of expert insights on global industries. Updated daily. For more information, contact Matt Seward at 301-468-3650 x205 or [email protected], or visit www.MarketResearch.com. "
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist
(20min delay)
Last
57.5¢
Change
-0.015(2.54%)
Mkt cap ! $41.49M
Open High Low Value Volume
57.5¢ 59.5¢ 57.0¢ $28.49K 49.24K

Buyers (Bids)

No. Vol. Price($)
1 210 57.5¢
 

Sellers (Offers)

Price($) Vol. No.
59.0¢ 5000 1
View Market Depth
Last trade - 14.54pm 17/02/2020 (20 minute delay) ?
(live)
Last
58.5¢
  Change
-0.015 ( 0.85 %)
Open High Low Volume
57.5¢ 58.5¢ 57.0¢ 9067
Last updated 14.52pm 17/02/2020 (live) ?
KZA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.